SEC Form 4 · accession 0000899243-15-003610
BG Medicine, Inc. · BGMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul R Sohmer
Officer — President & CEO · Director
Period of report
Aug 15, 2015
Accepted (ET)
Aug 19, 2015 · 8:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001407038
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 15, 2015 | F | 13,321 | $0.83 | D | 68,654 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Relates to shares withheld for payment of tax liability upon vesting of restricted stock units ("RSUs"). The RSUs were granted on October 16, 2014 and vested as to 50% on August 15, 2015, resulting in a net issuance to the holder of 27,667 shares.
- F2Represents 27,667 shares of common stock and 40,987 RSUs.